Sodium-glucose co-transporter 2 inhibitors and the potential for cardiovascular risk reduction in patients with type 2 diabetes mellitus.

Postgraduate medicine

Volumn 125, Issue 3, 2013, Pages 21-32

  Guthrie, Robert M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; LIPID; SODIUM GLUCOSE COTRANSPORTER 2;

ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; RISK FACTORS; SODIUM-GLUCOSE TRANSPORTER 2;

EID: 84882247716     PISSN: None     EISSN: 19419260     Source Type: None    
DOI: 10.3810/pgm.2013.05.2654     Document Type: Article

References (0)